New Tumaini Ebola vaccine trial launches in Bunia as DRC struggles

A clinical trial for a new Ebola vaccine is getting underway in DR Congo's Ituri province. The Tumaini trial will evaluate candidate vaccines against the Bundibugyo strain of the virus. There's currently no treatment or jab for Bundibugyo, which is driving the DRC's worst-ever Ebola outbreak. This event is of particular importance. It reflects our shared determination not to passively accept health threats, but to mobilize all available resources. The trial is led by the DRC's National Institute for Biomedical Research, with support from the World Health Organization. The DRC has been battling the outbreak since mid-May. Kenya has reported nine cases, and Nigeria confirmed its first case this week.